Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- S.5002
S.5002: FDA Modernization Act 2.0
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced Sept. 29, 2022
- Latest Major Action Sept. 29, 2022
Bill Sponsor
Bill Cosponsors
11 (3 Democrats, 2 Independent Democrats, 6 Republicans)
Bill Versions
- Considered and Passed Senate - Sept. 29, 2022
- Engrossed in Senate - Sept. 29, 2022
Bill Summary
FDA Modernization Act 2.0 This bill authorizes the use of certain alternatives to animal testing, including cell-based assays and computer models, to obtain an exemption from the Food and Drug Administration to investigate the safety and effectiveness of a drug. The bill also removes a requirement to use animal studies as part of the process to obtain a license for a biological product that is biosimilar or interchangeable with another...
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| Sept. 29, 2022 |
Introduced in the Senate, read twice, considered, read the third time, and passed without amendment by Unanimous Consent.
|
| Sept. 29, 2022 |
Held at the desk.
|
| Sept. 29, 2022 |
Message on Senate action sent to the House.
|
| Sept. 29, 2022 |
Received in the House.
|
| Sept. 29, 2022 |
Introduced in the Senate, read twice, considered, read the third time, and passed without amendment by Unanimous Consent. (consideration: CR S5514-5515; text: CR S5514-5515)
|
| Sept. 29, 2022 |
Introduced in the Senate by Rand Paul (R-Ky.) |